Radiopharm Theranostics (RADX) Assets Average (2025)
Radiopharm Theranostics (RADX) has disclosed Assets Average for 1 consecutive years, with $79.3 million as the latest value for Q2 2025.
- Quarterly Assets Average changed N/A to $79.3 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $79.3 million through Jun 2025, changed N/A year-over-year, with the annual reading at $79.3 million for FY2025, N/A changed from the prior year.
- Assets Average for Q2 2025 was $79.3 million at Radiopharm Theranostics.
- The five-year high for Assets Average was $79.3 million in Q2 2025, with the low at $79.3 million in Q2 2025.